Myasthenia Matters:
Navigating a New Era of Treatment
Generalized Myasthenia Gravis (gMG) is a chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. Early recognition and prompt treatment are critical to improving patient outcomes and quality of life. This comprehensive learning center provides clinicians with evidence-based education spanning the full spectrum of gMG care—from foundational pathophysiology and diagnostic strategies to emerging therapeutic options and practical management approaches for optimizing long-term patient care.
Supported by an educational grant from Johnson & Johnson.
gMG Disease Statistics
Comprehensive data on prevalence, disease burden, clinical course, and care gaps in generalized Myasthenia Gravis.
Global Prevalence
15–329 per million
Varies widely by country/methodology
Global Incidence
1.7–28 per million/year
Depends on age, antibody status
U.S. Prevalence
35.7 per 100,000
Claims-based; may undercount
U.S. Incidence
4.3 per 100,000 annually
Based on insurance claims
Trend Over Time
Doubled since 1950s
Better diagnosis, aging population
Data compiled from multiple sources including epidemiological studies, clinical trials, and registry data.
Educational Programs
Explore curated gMG-focused educational activities featuring expert faculty, clinical insights, and practical care strategies.
Expert Faculty & Steering Committee
Our distinguished steering committee comprises leading experts in Myasthenia Gravis management, bringing together renowned clinicians, researchers, and thought leaders dedicated to advancing gMG care and education.
Neelam Goyal
Stanford University, Palo Alto, CA
Nicholas J. Silvestri
University at Buffalo, Buffalo, NY
Hans Katzberg
University of Toronto, Canada
Jonathan Strober
University of California, San Francisco
Pushpa Narayanaswami
Beth Israel Deaconess Medical Center / Harvard
Gil I. Wolfe
University at Buffalo
Diana Castro
UT Southwestern / Dallas Children's Health
Vera Bril
University of Toronto & UHN
Richard J. Nowak
Yale University
Resource Center
Core clinical guidance, international consensus guidelines, diagnostic standards, and safety monitoring resources for gMG management.
Global Conference Calendar
Stay informed about upcoming conferences and congresses focused on Myasthenia Gravis research and clinical practice.
| Conference Name | Date | Location | Type | Link |
|---|---|---|---|---|
| MGFA International Conference on Myasthenia & Related Disorders | May 13-15, 2025 | Den Haag, The Netherlands | In-Person | |
| Child Neurology Society 54th Annual Meeting | October 8-11, 2025 | Charlotte, NC | In-Person | |
| American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting | October 29 - November 1, 2025 | San Francisco, CA | In-Person | |
| Advancing Myasthenia Gravis (MG) Treatment Through Guideline Updates and Emerging Therapies | October 30, 2025 | San Francisco, CA | In-Person | |
| Advancing Myasthenia Gravis (MG) Treatment Through Guideline Updates and Emerging Therapies | October 30, 2025 | Virtual | Virtual | |
| Annual Meeting of the American Academy of Neurology (AAN) | April 18-22, 2026 | Chicago, Illinois | In-Person | |
| Child Neurology Society 55th Annual Meeting | October 14-17, 2026 | Montreal, QC | In-Person |